trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide

C20H25N3O2 — CID 135907141

IUPACtrans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide
SMILESCC(C)=C[C@@H]1[C@H](C(=O)N(C)Cc2nc3ccccc3c(=O)[nH]2)C1(C)C
InChIInChI=1S/C20H25N3O2/c1-12(2)10-14-17(20(14,3)4)19(25)23(5)11-16-21-15-9-7-6-8-13(15)18(24)22-16/h6-10,14,17H,11H2,1-5H3,(H,21,22,24)/t14-,17-/m1/s1
InChIKeyMLFJUJLOSFVOFI-RHSMWYFYSA-N
MW339.44 g/mol
LogP3.12
Rot. Bonds4

About trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide

trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide (PubChem CID 135907141) has the molecular formula C20H25N3O2 and a molecular weight of 339.44 g/mol. Its IUPAC name is trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide.

Molecular Properties

Compound Nametrans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide
PubChem CID135907141
Molecular FormulaC20H25N3O2
Molecular Weight339.44 g/mol
Exact Mass339.19
IUPAC Nametrans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide
SMILESCC(C)=C[C@@H]1[C@H](C(=O)N(C)Cc2nc3ccccc3c(=O)[nH]2)C1(C)C
InChIInChI=1S/C20H25N3O2/c1-12(2)10-14-17(20(14,3)4)19(25)23(5)11-16-21-15-9-7-6-8-13(15)18(24)22-16/h6-10,14,17H,11H2,1-5H3,(H,21,22,24)/t14-,17-/m1/s1
InChIKeyMLFJUJLOSFVOFI-RHSMWYFYSA-N
XLogP3.12
TPSA66.06 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500339.44
LogP ≤ 53.12
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide?
The IUPAC name of trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide (CID 135907141) is trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide.
What is the SMILES notation for trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide?
The canonical SMILES for trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide is CC(C)=C[C@@H]1[C@H](C(=O)N(C)Cc2nc3ccccc3c(=O)[nH]2)C1(C)C.
What is the InChIKey of trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide?
The InChIKey is MLFJUJLOSFVOFI-RHSMWYFYSA-N. The full InChI is InChI=1S/C20H25N3O2/c1-12(2)10-14-17(20(14,3)4)19(25)23(5)11-16-21-15-9-7-6-8-13(15)18(24)22-16/h6-10,14,17H,11H2,1-5H3,(H,21,22,24)/t14-,17-/m1/s1.
What are the key properties of trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide?
trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide has a molecular weight of 339.44 g/mol, XLogP of 3.12, 4 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for trans-(1S,3R)-N,2,2-trimethyl-3-(2-methylprop-1-enyl)-N-[(4-oxo-3H-quinazolin-2-yl)methyl]cyclopropane-1-carboxamide is sourced from PubChem (CID 135907141), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).